Pacifica Partners Inc. Purchases 7,605 Shares of Colgate-Palmolive Company $CL

Pacifica Partners Inc. increased its position in Colgate-Palmolive Company (NYSE:CL) by 681.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,721 shares of the company’s stock after acquiring an additional 7,605 shares during the period. Pacifica Partners Inc.’s holdings in Colgate-Palmolive were worth $678,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the last quarter. Woodline Partners LP lifted its holdings in shares of Colgate-Palmolive by 76.3% during the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after purchasing an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. boosted its position in shares of Colgate-Palmolive by 2.0% during the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after buying an additional 245 shares during the last quarter. MAI Capital Management increased its holdings in Colgate-Palmolive by 1.0% in the 2nd quarter. MAI Capital Management now owns 45,845 shares of the company’s stock worth $4,167,000 after buying an additional 439 shares in the last quarter. Finally, Mufg Securities Americas Inc. increased its holdings in Colgate-Palmolive by 25.0% in the 2nd quarter. Mufg Securities Americas Inc. now owns 17,961 shares of the company’s stock worth $1,633,000 after buying an additional 3,596 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares of the company’s stock, valued at $1,306,757.53. The trade was a 53.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the sale, the insider owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This trade represents a 54.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 184,683 shares of company stock worth $17,486,693. 0.41% of the stock is owned by insiders.

Colgate-Palmolive Trading Down 0.4%

Colgate-Palmolive stock opened at $85.14 on Monday. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a market cap of $68.62 billion, a P/E ratio of 32.49, a P/E/G ratio of 3.81 and a beta of 0.28. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The business has a 50-day simple moving average of $91.01 and a two-hundred day simple moving average of $83.36.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 EPS. Analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.5%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Analysts Set New Price Targets

Several research firms have issued reports on CL. Rothschild & Co Redburn set a $93.00 target price on shares of Colgate-Palmolive in a research note on Friday, February 13th. JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research report on Tuesday, December 9th. The Goldman Sachs Group restated a “buy” rating and issued a $100.00 target price on shares of Colgate-Palmolive in a report on Friday, February 20th. Finally, Barclays lifted their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.75.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.